Feature | August 14, 2013

Volumetric Breast Density Software Improves Accuracy in Calculation of Patient-Specific MGD in Breast Screening

Research at AAPM demonstrates that use of Volpara may improve accuracy of dose estimates during breast screening

Stock image

August 14, 2013 — The role of volumetric breast density assessment software to more accurately estimate the radiation dose received during breast screening was the focus of two landmark research papers presented at the 55th annual meeting of the American Association of Physicists in Medicine (AAPM), Aug. 4-8, in Indianapolis. The papers both took advantage of the volumetric breast density numbers generated by Matakina International’s Volpara imaging software to calculate personalized or patient-specific dose estimates, according to Matakina.

Currently, mammography systems generate a mean glandular dose (MGD) based on an assumption of a homogeneous mixture of fat and fibroglandular tissue in standard proportions. 

Ralph Highnam, CEO of Matakina, said “We all know it’s critical to keep radiation dose as low as possible whilst retaining high image quality, and yet the current dose estimates in mammography may significantly under or overestimate the actual patient dose because they generate calculations based on assumption of a homogeneous mixture of fat and fibroglandular tissue in standard, non-personalized proportions. These talks show that it is possible to improve the accuracy and personalization of radiation dose estimation, which may, in turn, allow for better optimization of radiation dose in breast screening, both in mammography and tomosynthesis.”

The first study, “Patient Specific Average Glandular Dose in Mammography,” demonstrated the differences in radiation dose estimation when researchers adjusted the estimation according to the actual volumetric breast density. According to Vikas Patel, M.D., from Upstate Medical Physics (a Landauer Medical Physics partner), the results showed that accounting for the patient-specific breast composition led to estimated radiation doses which were significantly higher than given out by the mammography machines. “Our initial results suggest that current dose estimations may underestimate the actual patient MGD significantly as they do not account for the specific breast tissue composition. Patient-specific dose estimates may give a better indication of the actual dose delivered, and therefore the risk to the patient.”

The second study, “Retrospective Determination of Personalized Mean Glandular Dose Coefficients for Conventional Mammography Using Heterogeneously-layered Breast Models,” by Mariela Porras-Chaverri, department of medical physics, University of Wisconsin-Madison, took the personalization one stage further by not only using the patient-specific volumetric breast density, but also considering how the tissue might be dispersed within the breast. “The glandular and adipose breast tissues are distributed heterogeneously within the breast. Depending on the individual distribution with respect to the beam entrance surface, the mean dose delivered to the glandular tissue may be higher or lower than estimated by the current methods. Our ongoing study aims to provide a means to account for the heterogeneous distribution of the glandular tissue in estimates of mean glandular dose."

Cleared by the U.S. Food and Drug Administration (FDA), HealthCanada, the TGA and CE-marked, Volpara is in use at sites across the globe, helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening. Volpara is a reliable tool which generates objective, automatic measurement of volumetric breast density and a FDA-cleared BI-RADS breast density category. Volpara supports most of the major digital mammography systems, can be displayed on digital mammography and PACS (picture archiving and communications system) workstations and be integrated into mammography reporting systems.

For more information: www.volparadensity.com

Related Content

Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
Veterans Integrated Service Network 19 Implements System-Wide Radiation Dose Monitoring
News | Radiation Dose Management | December 04, 2018
Agfa HealthCare announced it has collaborated in delivering a system-wide DoseMonitor automated software implementation...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...